UPDATE 1-MEI Pharma shares crash as cancer drug fails mid-stage test

March 23 (Reuters) - MEI Pharma was set to lose more than half its market value on Monday after the company's cancer drug failed to meet the main goal in a mid-stage study.

from Reuters: Hot Stocks http://ift.tt/1DOdNzH